Transition and Co-Financing Review for the Global Fund


All Global Fund-supported countries must at some point prepare for the winding down of external support. For their final grant or “transition grant”, the country submits an application and receives an allocation that emphasizes sustainability and transition goals.

To date, there has not yet been a systematic review of the transition grants to synthesize key challenges, risks, and best practices across the Global Fund portfolio of transition grants.


Pharos has been engaged by the Global Fund to conduct an internal analysis of ten of the transition grants for countries transitioning in the end of 2021 or 2022. The ten countries of analysis span the globe: Albania, Algeria, Belize, Botswana, Dominican Republic, Panama, Paraguay, Romania, Sri Lanka, and Suriname. In addition to the ten countries for transition and co-financing, we are conducting co-financing deep dives for El Salvador and Guyana.

Collaborating with Fund Portfolio Managers, Sustainability Officers, and other Global Fund staff, we are asking the following questions:

  • Is the grant achieving its objectives and how are they performing (programmatically, financially, and otherwise) when it comes to transition?
  • How has the current Covid-19 context affected the disease programs and the overall country context?
  • Is the country prepared for a successful transition? If not, what precise actions can be taken to correct its course?


Pharos is producing ten slide decks for internal use only at the Global Fund and will be involved in conversations at the Global Fund about these ten countries. The Pharos team’s advice will be taken into consideration for the future of the ten transition grants and onwards into how the Global Fund conducts its transition process.

Status: Completed, October 2021

Team Members Involved: Robert Hecht, Catalina Gutierrez, Alexa Straus, Aishwarya Bhattacharya, and Nathan Isaacs

For more information, contact Nathan Isaacs at

LEARN MORE about Pharos Global Health Advisors response to the COVID-19 pandemic.